|By ACN Newswire||
|March 11, 2014 03:28 AM EDT||
Enhanced BioEntry W Access Control Terminal integrated with HID iCLASS SE as well as with Enhancements for FeliCa
In conjunction with the expansion of its RF technology, the enhanced BioEntry W was upgraded with HID iCLASS SE as well as enhancements for FeliCa IC cards which are most widely used in Japan and the region.
BioEntry W exquisitely blends benefits of an IP access control system with high-level security provided by fingerprint biometrics. Featuring a vandal-resistance and IP65 rated structure, BioEntry W is ideally designed for outdoor installation while offering exceptional durability in harsh environments. With its extensive communication interfaces and PoE (Power over Ethernet) capability, it is the ultimate outdoor fingerprint terminal for access control systems in the global market.
With this enhanced version BioEntry W and its robust market presence serving as momentum, Suprema plans to reinforce and expand its business and marketing strategies globally.
"Like the new BioEntry W, integration with a global leader like HID is significantly meaningful for biometrics and security markets' advancement as well as for growth of Suprema," said Young S. Moon, vice president of Suprema. "Such partnership for integration is essential in establishing milestones from the view of ceaseless provision of state-of-the art technology and products bringing higher value-added benefits to customers and end users."
About Suprema Inc.
Suprema Inc. is a leading global provider of biometric technology and identity management solutions. The company's range of products includes fingerprint modules, biometric access control systems, e-passport readers and live-scanners. Suprema has worldwide sales network in over 110 countries and also a listed company in stock exchange in South Korea (KOSDAQ). For further information, visit www.supremainc.com/eng.
Source: Suprema Inc.
David Kim (PAN HEE) Manager, PR & Marketing BMS, Suprema Inc. O: +82 31 710 5619 F: +82 31 783 4503 M: +82 10 5585 1810 [email protected]
Copyright 2014 ACN Newswire. All rights reserved.